Sophia Randolph, Chief Medical Officer at ALX ONCOLOGY HOLDINGS INC (ALXO), sold 14,774 shares at $59.80 ($899K) on 2021-06-10, disclosed to the SEC on 2021-06-14.
Open-market sale of $899k ALXO by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.80 | 1,188 | $71K | 7.9% |
| 2 | $59.80 | 1,188 | $71K | 7.9% |
| 3 | $60.90 | 4,405 | $268K | 29.8% |
| 4 | $60.90 | 4,405 | $268K | 29.8% |
| 5 | $61.53 | 1,794 | $110K | 12.3% |
| 6 | $61.53 | 1,794 |
| $110K |
| 12.3% |
| Total | $60.88 avg | 14,774 | $899K | 100% |
| Filing → |
| ALXO | SELL | 2024-05-15 | $353K | — | Filing → |
| ALXO | SELL | 2024-01-03 | $47K | — | Filing → |
| ALXO | SELL | 2023-07-05 | $12K | — | Filing → |